Results
|
7581.
|
|
|
7582.
|
|
|
7583.
|
|
|
7584.
|
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups. [electronic resource] by
- Freyer, G
- Rougier, P
- Bugat, R
- Droz, J P
- Marty, M
- Bleiberg, H
- Mignard, D
- Awad, L
- Herait, P
- Culine, S
- Trillet-Lenoir, V
Producer: 20000822
In:
British journal of cancer vol. 83
Availability: No items available.
|
|
7585.
|
|
|
7586.
|
|
|
7587.
|
|
|
7588.
|
|
|
7589.
|
|
|
7590.
|
|
|
7591.
|
|
|
7592.
|
|
|
7593.
|
|
|
7594.
|
|
|
7595.
|
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib. [electronic resource] by
- Thiam, R
- Fournier, L S
- Trinquart, L
- Medioni, J
- Chatellier, G
- Balvay, D
- Escudier, B
- Dromain, C
- Cuenod, C A
- Oudard, S
Producer: 20100817
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
7596.
|
|
|
7597.
|
|
|
7598.
|
|
|
7599.
|
|
|
7600.
|
|